ANAVO THERAPEUTICS
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications
ANAVO THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2020-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.anavotx.com
Total Employee:
1+
Status:
Active
Total Funding:
28.5 M EUR
Technology used in webpage:
Domain Not Resolving CrUX Top 50m CrUX Dataset Pound Sterling Amazon Route 53
Similar Organizations
Ajax Therapeutics
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bioqube Ventures
Bioqube Ventures investment in Seed Round - Anavo Therapeutics
Inkef
Inkef investment in Seed Round - Anavo Therapeutics
M Ventures
M Ventures investment in Seed Round - Anavo Therapeutics
Taiho Ventures
Taiho Ventures investment in Seed Round - Anavo Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Seed Round - Anavo Therapeutics
M Ventures
M Ventures investment in Seed Round - Anavo Therapeutics
Bioqube Ventures
Bioqube Ventures investment in Seed Round - Anavo Therapeutics
Taiho Ventures
Taiho Ventures investment in Seed Round - Anavo Therapeutics
Inkef
Inkef investment in Seed Round - Anavo Therapeutics
Official Site Inspections
http://www.anavotx.com Semrush global rank: 6.07 M Semrush visits lastest month: 1.13 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Anavo Therapeutics"
Anavo Therapeutics
If you are interested in becoming a part of this journey, please send your resume to [email protected]. News & Events. 10.09.24 Anavo Therapeutics Appoints Dr. Edward โฆSee details»
Anavo Therapeutics - Crunchbase Company Profile & Funding
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.See details»
8-16-21 - Anavo to Establish R&D Hub in World ... - Anavo โฆ
Aug 16, 2021 Leiden, The Netherlands, and Heidelberg, Germany, August 16, 2021 โ Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase โฆSee details»
BIRGIT ZECH, CEO โ Anavo Therapeutics
With 20 years of experience working in the biotechnology sector in the EU and US, Birgit brings significant competence to Anavo in areas such as Operations, Business Development and โฆSee details»
Anavo Therapeutics GmbH - life-sciences-europe.com
Https://www.anavotx.com Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have โฆSee details»
Anavo Therapeutics Appoints Dr. Edward Holson as Chief Scientific ...
Oct 9, 2024 Anavo is backed by blue-chip investors M Ventures, an affiliate of Merck KGaA, Darmstadt, Germany, INKEF Capital, Taiho Ventures, MRL Ventures Fund, and Bioqube โฆSee details»
Anavo Therapeutics | EU-Startups
Articles about Anavo Therapeutics: June 14, 2023 74 Top Biotechnology Startups and Companies in The Netherlands (2021); May 5, 2023 Weekly funding round-up! All of the European startup โฆSee details»
Anavo Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Anavo Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
12-9-21-Anavo Therapeutics Announces the Appointment of โฆ
Dec 9, 2021 Leiden, The Netherlands, and Heidelberg, Germany, December 09, 2021 โ Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase โฆSee details»
Anavo Therapeutics - Overview, News & Similar companies
Sep 21, 2023 www.anavotx.com. Revenue $7.9 Million. Industry Pharmaceuticals Healthcare . Most Recent Scoops. Sep 21 2023. Left Company. Sep 21 2023. New Hire. Shaun McNulty โฆSee details»
Anavo Therapeutics extends Seed Round to EUR 28 Million to โฆ
May 2, 2023 Anavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected]. Media Contact Chelsea Rule MacDougall Advisors +1 781-235-3060 โฆSee details»
Anavo Therapeutics Appoints Dr. Edward Holson as Chief Scientific ...
Oct 9, 2024 Anavo is backed by blue-chip investors M Ventures, an affiliate of Merck KGaA, Darmstadt, Germany, INKEF Capital, Taiho Ventures, MRL Ventures Fund, and Bioqube โฆSee details»
Anavo Therapeutics BV (Anavo Therapeutics BV) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
Apr 1, 2025 The company appoints industry veteran Shaun McNulty as Chief Scientific Officer and welcomes R&D expert Anna Quattropani as Senior Vice President of Chemistry & Non โฆSee details»
JOE LEWIS, PHD, MBA - Anavo Therapeutics
Joe is Senior Vice President of Biology and Site Head Heidelberg at Anavo. He has over twenty-five years of experience in industry and academic roles and has a broad knowledge of small โฆSee details»
Anavo Therapeutics - VentureRadar
May 6, 2021 "Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.See details»
Anavo Therapeutics to Establish R&D Hub in World-Leading โฆ
Aug 16, 2021 Back to the news overview. Anavo Therapeutics to Establish R&D Hub in World-Leading Cancer Research Cluster. Leiden, The Netherlands, and Heidelberg, Germany, โฆSee details»
Anavo Therapeutics Appoints Dr. Edward Holson as Chief
Oct 9, 2024 For more information, please visit: www.anavotx.com. Contacts. Anavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected]. โฆSee details»
NAVEX Announces Andrew Bates as New Chief Executive Officer
2 days ago Portland, Ore โ April 28, 2025 โ NAVEX, the global leader in integrated risk and compliance management software, announced today that Andrew Bates has been appointed โฆSee details»
Anavo Therapeutics Announces the Appointment of Charles โฆ
Dec 9, 2021 Anavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected]. Media Matthew Corcoran and Amanda Houlihan MacDougall +1 781 โฆSee details»
Privacy Statement - Anavo Therapeutics
- Organization - Language. Our processing basis is our legitimate interest to be able to respond to your questions and requests and to be able to improve our services and the website. D. If you โฆSee details»